triptolide has been researched along with Bladder Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, XG; Ding, M; Jin, ZL; Xu, HJ; Yang, Y; Zhang, LJ | 1 |
| Ding, Y; Gao, W; Li, D; Sun, Y; Wang, T; Wang, Z; Wei, J; Yang, Y | 1 |
| Byun, SS; Ho, JN; Hong, SK; Lee, S; Lee, SE; Oh, JJ; Yeon, JS | 1 |
| Chen, J; Guo, Z; Pei, XF; Underhill, CB; Wang, L; Xu, XM; Yang, J; Yang, S; Zhang, L | 1 |
4 other study(ies) available for triptolide and Bladder Cancer
| Article | Year |
|---|---|
Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Diterpenes; Dose-Response Relationship, Drug; Drug Synergism; Epoxy Compounds; G1 Phase Cell Cycle Checkpoints; Gemcitabine; Glycogen Synthase Kinase 3 beta; Humans; Phenanthrenes; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Urinary Bladder Neoplasms | 2018 |
Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diterpenes; Drug Synergism; Epoxy Compounds; Mice, Inbred BALB C; Mice, Nude; Phenanthrenes; Reactive Oxygen Species; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diterpenes; Drug Resistance, Neoplasm; Drug Synergism; Epoxy Compounds; Humans; Phenanthrenes; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2015 |
Triptolide inhibits the growth and metastasis of solid tumors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Breast Neoplasms; Cell Division; Diterpenes; Epoxy Compounds; Female; Humans; Melanoma; Melanoma, Experimental; Mice; Neoplasm Metastasis; Phenanthrenes; Stomach Neoplasms; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |